Identification of Juglone, a ‘first-in-class’ inhibitor of the human glutathione degrading enzyme, ChaC1, using yeast-based high throughput screens
Preprint
Abstract
The cytosolic glutathione-degrading enzyme, ChaC1, is highly upregulated in several cancers, with the upregulation correlating to poor prognosis. The ability to inhibit ChaC1 thus becomes important in pathophysiological situations where elevated glutathione levels would be beneficial. As no inhibitors of ChaC1 are known, in this study we have focussed on this goal. We have initially taken a computational approach where a systemic structure-based virtual screening was performed. However, none of the predicted hits proved to be effective inhibitors. We also evaluated synthetic substrate analogs, but these too were not inhibitory. As both these approaches targeted the active site, we shifted to developing two high-throughput, robust, yeast-based assays that were active site independent. A small molecule compound library was screened using an automated liquid handling system using these screens. The hits were further analyzed using in vitro assays. Among them, juglone, a naturally occurring naphthoquinone, completely inhibited ChaC1 activity with an IC 50 of 8.7 µM. It was also effective against the ChaC2 enzyme. Kinetic studies indicated that the inhibition was not competitive with the substrate. Juglone is known to form adducts with glutathione and is also known to selectively inhibit enzymes by covalently binding to their active site cysteine residues. However, juglone continued to inhibit a cysteine-free ChaC1 variant, indicating that it was acting through a novel mechanism. We evaluated different inhibitory mechanisms, and also analogues of juglone, and found plumbagin effective as an inhibitor. These compounds represent the ‘first-in-class’ inhibitors of the ChaC enzymes discovered using a robust yeast screen.Keywords
This publication has 36 references indexed in Scilit:
- ChaC1 upregulation reflects poor prognosis in a variety of cancers: analysis of the major missense SNPs of ChaC1 as an aid to refining prognosisGene, 2024
- The ChaC1 active site: Defining the residues and determining the role of ChaC1‐exclusive residues in the structural and functional stabilityProteins: Structure, Function, and Bioinformatics, 2022
- Gambogic acid and juglone inhibit RNase P through distinct mechanismsJournal of Biological Chemistry, 2022
- Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of developmentBiomedicine & Pharmacotherapy, 2022
- Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patientsInternational Ophthalmology, 2019
- Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase ABioorganic & Medicinal Chemistry Letters, 2018
- Amino Acid Starvation Induced by Invasive Bacterial Pathogens Triggers an Innate Host Defense ProgramCell Host & Microbe, 2012
- Epik: a software program for pK a prediction and protonation state generation for drug-like moleculesJournal of Computer-Aided Molecular Design, 2007
- Glutathione depletion leads to delayed growth stasis in Saccharomyces cerevisiae : evidence of a partially overlapping role for thioredoxinCurrent Genetics, 2000
- Semiquinone anion radicals formed by the reaction of quinones with glutathione or amino acidsFEBS Letters, 1986